[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:hepatitis-c-infection":3},{"name":4,"total":5,"recruiting":6,"trials":7},"Hepatitis C Infection",23,19,[8,16,23,29,35,41,47,53,59,65,72,78,84,90,96,102,108,114,120,126,133,139,145],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07479979","Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and\u002For Refractory Multiple Myeloma",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:18:35.425468Z","2026-05-29T15:36:40.195056Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07433673","Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)",[20],"Phase 2","2026-08-26T02:19:08.084946Z","2026-05-05T02:43:29.707381Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT05655949","Y-90 With Durvalumab\u002FGem\u002FCis in Intrahepatic Cholangio",[20],"2026-08-26T02:15:36.077529Z","2026-05-05T02:43:29.327321Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT05797805","A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma",[12],"2026-08-26T02:17:11.311767Z","2026-05-05T02:43:29.284306Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT07040319","Study of the Pharmacokinetics and Safety of Glecaprevir\u002FPibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV",[12],"2026-08-26T02:16:18.872924Z","2026-05-05T02:43:28.558929Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT05967182","A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma",[20],"2026-08-26T02:18:24.494016Z","2026-05-05T02:43:28.207276Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT04305691","Trial of Ixazomib for Kaposi Sarcoma",[20],"2026-08-26T02:19:21.761002Z","2026-05-05T02:43:28.178229Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT07222488","A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)",[12],"2026-08-26T02:18:05.435729Z","2026-05-05T02:43:28.130472Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":63,"content_modified":64},"NCT06052618","Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)",[20],"2026-08-26T02:19:05.360997Z","2026-05-05T02:43:27.493473Z",{"nct_id":66,"title":67,"phases":68,"status":13,"updated_at":70,"content_modified":71},"NCT05096715","Atezolizumab+Bevacizumab+SBRT in Unresectable HCC",[69],"Phase 1","2026-08-26T02:16:41.943926Z","2026-05-05T02:43:27.321203Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT06569147","Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis",[12],"2026-08-26T02:18:17.950264Z","2026-05-05T02:43:27.288200Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT06818643","A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)",[12],"2026-08-26T02:18:08.005333Z","2026-05-05T02:43:26.902550Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT04941274","Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma",[12],"2026-08-26T02:16:54.044282Z","2026-05-05T02:43:26.742813Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT06213311","A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma",[20],"2026-08-26T02:17:01.714035Z","2026-04-29T02:57:57.157278Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT04524871","A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)",[12],"2026-08-26T02:18:51.833592Z","2026-04-29T02:57:57.128598Z",{"nct_id":103,"title":104,"phases":105,"status":13,"updated_at":106,"content_modified":107},"NCT05681195","Zanubrutinib With Pemetrexed to Treat Relapsed\u002FRefractory Primary and Secondary Central Nervous System (CNS) Lymphomas",[20],"2026-08-26T02:19:18.331180Z","2026-05-05T02:43:28.471359Z",{"nct_id":109,"title":110,"phases":111,"status":13,"updated_at":112,"content_modified":113},"NCT05486572","Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI",[],"2026-08-26T02:15:37.042762Z","2026-05-05T02:43:29.351159Z",{"nct_id":115,"title":116,"phases":117,"status":13,"updated_at":118,"content_modified":119},"NCT05368974","The Treatment in Pregnancy for Hepatitis C (\"TiP-HepC\") Registry",[],"2026-08-26T02:18:46.137046Z","2026-05-13T02:55:06.301982Z",{"nct_id":121,"title":122,"phases":123,"status":13,"updated_at":124,"content_modified":125},"NCT04493385","The Hepatitis C Transplant Collaborative",[],"2026-08-26T02:18:42.501841Z","2026-05-13T02:55:06.251258Z",{"nct_id":127,"title":128,"phases":129,"status":130,"updated_at":131,"content_modified":132},"NCT07672483","IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors",[69],"NOT_YET_RECRUITING","2026-08-26T02:17:02.694423Z","2026-07-05T03:45:20.432490Z",{"nct_id":134,"title":135,"phases":136,"status":130,"updated_at":137,"content_modified":138},"NCT07557056","Nemtabrutinib and Venetoclax for the Treatment of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma",[20],"2026-08-26T02:18:43.501109Z","2026-05-13T02:55:06.723790Z",{"nct_id":140,"title":141,"phases":142,"status":130,"updated_at":143,"content_modified":144},"NCT07667400","Docetaxel and SX-682 in Recurrent\u002FMetastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer",[12],"2026-08-26T02:19:15.498463Z","2026-07-05T03:45:20.369129Z",{"nct_id":146,"title":147,"phases":148,"status":150,"updated_at":151,"content_modified":152},"NCT06782399","Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma",[149],"Early Phase 1","ENROLLING_BY_INVITATION","2026-08-26T02:17:07.954622Z","2026-06-16T05:54:07.770961Z"]